General Fluidics
Waltham
About General Fluidics
General Fluidics develops an in vitro diagnostic tool for performing a growing array of blood and urine tests. Its platform uses a patented hybrid hardware architecture, fluidics, and optoelectronic technologies to go beyond test results to deliver complete diagnostic information sets at the point of care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.5M
- Last round: Series Unknown (Jul 2024)
- Website: generalfluidics.com
- Phone: 857-702-2710
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/general-fluidics-44400 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.